Drug resistant tuberculosis contributes significantly to the global burden of antimicrobial
resistance, often consuming a large proportion of the healthcare budget and associated …

Drug-resistant tuberculosis (TB) is estimated to cause 13% of all antimicrobial resistance-
attributable deaths worldwide and is driven by both ongoing resistance acquisition and …

Tuberculosis (TB) is the second leading cause of death due to infectious diseases globally,
and delay in the TB care cascade is reported as one of the major challenges in achieving …

Aim We aimed to identify and describe the unmet needs of patients with multidrug-resistant
tuberculosis (MDR-TB). Methods As a part of larger cross-sectional mixed-methods …

Drug-resistant (DR) tuberculosis (TB) is a major public health concern globally, complicating
TB control and management efforts. West Africa has historically faced difficulty in combating …

Background Transmission is contributing to the slow decline of tuberculosis (TB) incidence
globally. Drivers of TB transmission in India, the country estimated to carry a quarter of the …

Tuberculosis (TB) poses a significant social and economic burden to households of persons
with TB (PwTB). Despite free diagnosis and care under the National TB Elimination …

Treatment decisions for tuberculosis (TB) in the absence of full drug-susceptibility data can
result in amplifying resistance and may compromise treatment outcomes. Genomics of …

Globally, an estimated 1· 2 million cases of tuberculosis disease each year occur in children
younger than 15 years, and around 67 million children have tuberculosis infection, putting …

Minority variants of Mycobacterium tuberculosis harboring mutations conferring resistance
can become dominant populations during tuberculosis (TB) treatment, leading to treatment …